Jury Awards $1.5M For Breast Cancer from Prempro

A Puerto Rican jury has awarded $1.5 million in compensation to a woman who claimed that she developed breast cancer from Prempro hormone replacement therapy (HRT)

Helen Rivera-Adams, a 62-year-old pharmacist in San Juan, currently going through the late stages of breast cancer, filed the Prempro lawsuit against Pfizer’s Wyeth unit for failing to warn her or her doctors that the medication may increase the risk of breast cancer.

Prempro is a hormone replacement therapy (HRT) that contains a combination of the drugs Provera and Premarin. The drug was originally developed by Wyeth, which was acquired by Pfizer last year.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

HRTs use hormones and progestins to artificially boost hormone levels in women undergoing menopause due to surgery or in postmenopausal women, to provide relief from symptoms such as hot flashes, irregular menstruation or weight gain.

Rivera-Adams was diagnosed with breast cancer in January 2002, after taking Prempro for about 19 months. The lawsuit sought $8 million in damages. Pfizer said it is considering its legal options.

In 2002 the National Institutes of Health released the results of studies that found women receiving HRT were at higher risk of breast cancer, strokes and heart attacks. The studies, part of the Women’s Health Initiative, sparked most of the Prempro hormone replacement therapy lawsuits currently pending throughout the country.

There are now about 9,000 lawsuits over breast cancer from Prempro pending against Pfizer’s Wyeth unit by women who claim that they developed breast cancer from the medication. All of the lawsuits claim that the drug caused plaintiffs to develop breast cancer, and that Wyeth failed to warn patients and doctors of the potential side effects of the hormone therapy.

The jury’s decision in the Rivera-Adams case, which was issued December 30, came just about one month after the Nevada Supreme Court upheld a 2007 verdict that awarded three women in that state $58 million for HRT breast cancer, and after Pfizer won a defense verdict in another trial in Virginia.

Image Credit: |

3 Comments

  • JacquelynOctober 7, 2014 at 7:01 pm

    I've been taking prempro for 7 years, now in 9/2014 I've been diagnoised with breastt cancer, now what do we do or who do we have to represent us?

  • PaulaSeptember 1, 2013 at 5:20 pm

    In 2010 after receiving a hysterectomy I was giving the drug Estradiol for hormone replacement. In March of 2013 I was diagnosed with breast cancer and had bilateral mastectomies and am still under going chemo

  • graceMarch 25, 2011 at 5:13 pm

    ive just became aware that there is prove that hormones,prempro is a cause of breast ca.i had a double simple masectomy in june 08.it was 98% estorgen..whatever that means.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Third Track of Camp Lejeune Illnesses and Diseases To Be Selected For Case Specific Workup
Third Track of Camp Lejeune Illnesses and Diseases To Be Selected For Case Specific Workup (Posted yesterday)

The U.S. government has proposed claims of esophageal cancer, miscarriage, dental side effects, and hypersensitivity skin disorder be used for a third batch of potential Camp Lejeune bellwether lawsuits.